Interleukin-1 is a key regulator of matrix metalloproteinase-9 expression in human neurons in culture and following mouse brain trauma in vivo
Data up to Jan 2025
Total Citations Per Year
Abstract
References (58)
Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis
1994 • 672 citations
Matrix metalloproteinases and diseases of the CNS
1998 • 646 citations
The Degradation of Human Endothelial Cell-derived Perlecan and Release of Bound Basic Fibroblast Growth Factor by Stromelysin, Collagenase, Plasmin, and Heparanases
1996 • 601 citations
Detection of interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury, by in vivo microdialysis: evidence of a role for microglia in cytokine production
1991 • 579 citations
Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion
1993 • 517 citations
The AP-1 site and MMP gene regulation: What is all the fuss about?
1997 • 507 citations
CNTF Protection of Oligodendrocytes Against Natural and Tumor Necrosis Factor-Induced Death
1993 • 486 citations
Interferon β‐1b decreases the migration of T lymphocytes in vitro: Effects on matrix metalloproteinase‐9
1996 • 363 citations
Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines
1994 • 343 citations
Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases.
1994 • 338 citations
Induction of Interleukin‐1β mRNA in Rat Brain After Transient Forebrain Ischemia
1992 • 336 citations
Interferon beta‐1b inhibits gelatinase secretion and in vitro migration of human T cells: A possible mechanism for treatment efficacy in multiple sclerosis
1996 • 302 citations
Matrix Metalloproteinases in the Normal Human Central Nervous System, Microglial Nodules, and Multiple Sclerosis Lesions
1996 • 290 citations
Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
1996 • 278 citations
Neuronal Matrix Metalloproteinase-2 Degrades and Inactivates a Neurite-Inhibiting Chondroitin Sulfate Proteoglycan
1998 • 271 citations
Matrix Metalloproteinase-9/Gelatinase B Is Required for Process Outgrowth by Oligodendrocytes
1999 • 268 citations
Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system
1999 • 268 citations
Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke
1997 • 265 citations
Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states.
1998 • 262 citations
Interleukin-1 receptor antagonist inhibits neuronal damage caused by fluid percussion injury in the rat
1995 • 252 citations
The Expression of Tissue-type Plasminogen Activator, Matrix Metalloproteases and Endogenous Inhibitors in the Central Nervous System in Multiple Sclerosis
1996 • 247 citations
Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion.
1995 • 238 citations
Membrane-type 1 Matrix Metalloprotease (MT1-MMP) Enables Invasive Migration of Glioma Cells in Central Nervous System White Matter
1999 • 236 citations
Cytokines Regulate Gelatinase A and B (Matrix Metalloproteinase 2 and 9) Activity in Cultured Rat Astrocytes
1995 • 193 citations
Expression of Matrix Metalloproteinases and Their Tissue Inhibitors in Human Brain Tumors
1998 • 185 citations
Interleukin 3 as a trophic factor for central cholinergic neurons in vitro and in vivo
1990 • 184 citations
Attenuation of Astroglial Reactivity by Interleukin-10
1996 • 182 citations
Differential susceptibility of human CNS-derived cell populations to TNF-dependent and independent immune-mediated injury
1995 • 180 citations
Matrix metalloproteinase expression in an experimentally-induced DTH model of multiple sclerosis in the rat CNS
1998 • 179 citations
Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-alpha, or IFN-gamma.
1999 • 174 citations
Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions
1997 • 169 citations
Biology of Adult Human Microglia in Culture: Comparisons with Peripheral Blood Monocytes and Astrocytes
1992 • 162 citations
Overexpression of interleukin-1 receptor antagonist in the mouse brain reduces ischemic brain injury
1997 • 159 citations
Increased production of gelatinase B (matrix metalloproteinase‐9) and interleukin‐6 by activated rat microglia in culture
1995 • 154 citations
Astrogliosis in the Neonatal and Adult Murine Brain Post-Trauma: Elevation of Inflammatory Cytokines and the Lack of Requirement for Endogenous Interferon-γ
1997 • 151 citations
Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31-9790
1995 • 146 citations
Oligodendrocytes utilize a matrix metalloproteinase, MMP-9, to extend processes along an astrocyte extracellular matrix
1998 • 143 citations
Fas Ligand and Fas Are Expressed Constitutively in Human Astrocytes and the Expression Increases with IL-1, IL-6, TNF-α, or IFN-γ
1999 • 142 citations
Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors
1998 • 124 citations
Monoclonal antibodies recognize individual neurofilament triplet proteins.
1982 • 121 citations
Chemokine modulation of matrix metalloproteinase and TIMP production in adult rat brain microglia and a human microglial cell line in vitro
1999 • 119 citations
Injury-induced 92-kilodalton gelatinase and urokinase expression in rat brain.
1994 • 115 citations
Interferon‐β Is a Potent Promoter of Nerve Growth Factor Production by Astrocytes
1997 • 91 citations
Co-expression of mRNA for Neurotrophic Factors in Human Neurons and Glial Cells in Culture
1994 • 77 citations
Delayed-type hypersensitivity lesions in the central nervous system are prevented by inhibitors of matrix metalloproteinases
1996 • 69 citations
MMP-9 (gelatinase B) mRNA is expressed during mouse neurogenesis and may be associated with vascularization
1995 • 67 citations
Co-localization of interleukin-1 receptor type I and interleukin-1 receptor antagonist with vasopressin in magnocellular neurons of the paraventricular and supraoptic nuclei of the rat hypothalamus
1999 • 46 citations
Oligodendrocyte‐type 2 Astrocyte Progenitors Use a Metalloendoprotease to Spread and Migrate on CNS Myelin
1997 • 41 citations
Prevention of acute autoimmune encephalomyelitis and abrogation of relapses in murine models of multiple sclerosis by the protease inhibitor D-penicillamine
1995 • 40 citations
Biphasic transforming growth factor-β production flanking the pro-inflammatory cytokine response in cerebral trauma
1995 • 38 citations
Biphasic transforming growth factor-β production flanking the pro-inflammatory cytokine response in cerebral trauma
1995 • 37 citations
The potential use of MMP inhibitors to treat CNS diseases
1999 • 36 citations
Differential expression of fibroblast growth factor receptors by human neurones, astrocytes, and microglia
1994 • 31 citations
Expression of extracellular matrix degrading enzymes during migration of xenografted brain cells
1999 • 25 citations
Clinical Neuroimmunology
1988 • 20 citations
Purification of cell populations from human fetal brain using flow cytometric techniques
1995 • 17 citations
Response of astrocytes and oligodendrocytes to injury
1998 • 14 citations
Studies on the binding of vitamin B12 by human saliva
1972 • 5 citations